A deep dive into future therapies for microcytic anemias and clinical considerations.

François RodriguesTereza ComanGuillemette FouquetFrancine CôtéGeneviève CourtoisThiago Trovati MacielOlivier Hermine

Published in: Expert review of hematology (2023)

As the genetic and cellular background of dyserythropoiesis will continue to be clarified, collaboration with bioengineering of treatments acting specifically at the protein domain level will continue to provide new therapies in haematology as well as oncology and neurology.

Keyphrases

palliative care
current status
genome wide
binding protein
copy number
amino acid
gene expression
small molecule